Full Schedule - Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!
Tuesday, October 27, 2026
10:15 AM - 11:15 AM PT
Bridging the Competency Gap: A Career Development Framework for PharmD students Interested in Managed Care
10:15 AM - 11:15 AM PT
(F1) Bridging the Competency Gap: A Career Development Framework for PharmD students Interested in Managed Care
Managed Care Fundamentals
10:15 AM - 11:15 AM PT
Optimizing the Use of JAK Inhibitors in Dermatology: Real-World Evidence, Indication Expansion, and Managed Care Strategies for Moderate Disease Management
10:15 AM - 11:15 AM PT
(D1) Optimizing the Use of JAK Inhibitors in Dermatology: Real-World Evidence, Indication Expansion, and Managed Care Strategies for Moderate Disease Management
Drugs, Diseases, and the Managed Care Impact
10:15 AM - 11:15 AM PT
The Commissioner's National Priority Voucher (CNPV) Pilot One Year Later: Real-World Approvals and Managed Care Impact
10:15 AM - 11:15 AM PT
(L1) The Commissioner's National Priority Voucher (CNPV) Pilot One Year Later: Real-World Approvals and Managed Care Impact
Legislative and Regulatory Trends
10:15 AM - 11:15 AM PT
The State of AI in Managed Care
10:15 AM - 11:15 AM PT
(W1) The State of AI in Managed Care
Making the Way for Innovation
1:45 PM - 2:45 PM PT
AI in Managed Care Pharmacy: Opportunities, Risks, and Readiness for Decision‑Makers
1:45 PM - 2:45 PM PT
(W2) AI in Managed Care Pharmacy: Opportunities, Risks, and Readiness for Decision‑Makers
Making the Way for Innovation
1:45 PM - 2:45 PM PT
Federal Legislative and Regulatory Update
1:45 PM - 2:45 PM PT
(L2) Federal Legislative and Regulatory Update
Legislative and Regulatory Trends
1:45 PM - 2:45 PM PT
Rare Disease Spotlight: Aligning Medical and Pharmacy Benefits in Neuromuscular Diseases
1:45 PM - 2:45 PM PT
(D2) Rare Disease Spotlight: Aligning Medical and Pharmacy Benefits in Neuromuscular Diseases
Drugs, Diseases, and the Managed Care Impact
1:45 PM - 2:45 PM PT
Repositioning of Biosimilars: How Can the U.S. Optimize Biosimilar Utilization to Improve Patient Health and Lower Total Cost of Care
1:45 PM - 2:45 PM PT
(R2) Repositioning of Biosimilars: How Can the U.S. Optimize Biosimilar Utilization to Improve Patient Health and Lower Total Cost of Care
Real-World Evidence and Research Translation
3:15 PM - 4:00 PM PT
Practice Over Promise: Payment and Coverage Access to Precision Medicine Through a Real-World Lens
3:15 PM - 4:00 PM PT
(R3) Practice Over Promise: Payment and Coverage Access to Precision Medicine Through a Real-World Lens
